Latest Imaging Technology News

Page 7 of 10
Pro Medicus Limited has entered a strategic financing arrangement with 4DMedical to accelerate the development and commercialization of cutting-edge lung function imaging software.
Ada Torres
Ada Torres
31 July 2025
4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.
Ada Torres
Ada Torres
31 July 2025
4DMedical reports a 56% revenue surge in FY25 alongside a strategic $10 million investment from Pro Medicus, advancing its CT, VQ™ lung imaging technology towards FDA clearance.
Ada Torres
Ada Torres
31 July 2025
Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.
Ada Torres
Ada Torres
31 July 2025
Finder Energy has fast-tracked its Kuda Tasi and Jahal (KTJ) oil field development in Timor-Leste through a strategic alliance with SLB, advancing key engineering design by 12 months and targeting a final investment decision in 2026. The company also strengthened its financial position with a $6 million placement, supporting ongoing exploration and development activities across its diverse portfolio.
Maxwell Dee
Maxwell Dee
31 July 2025
Micro-X has secured its first supply agreement with a leading US healthcare provider for its Rover Plus mobile radiology system, opening access to over 700 facilities nationwide.
Victor Sage
Victor Sage
30 July 2025
Imagion Biosystems has made significant progress towards filing an Investigational New Drug application for its MagSense® HER2 breast cancer imaging agent, receiving encouraging feedback from the FDA and preparing for a Phase 2 clinical trial.
Ada Torres
Ada Torres
29 July 2025
Clarity Pharmaceuticals has successfully completed recruitment for its pivotal Co-PSMA Phase II trial, testing its novel Cu-SAR-bisPSMA diagnostic against the current standard in detecting prostate cancer recurrence. This milestone advances their mission to improve early detection and treatment outcomes for men with low PSA levels.
Ada Torres
Ada Torres
17 July 2025
Imagion Biosystems has received encouraging feedback from the FDA on its MagSense HER2 breast cancer imaging program, clearing the path for a Phase 2 clinical trial and fast-tracking manufacturing.
Ada Torres
Ada Torres
15 July 2025
Imagion Biosystems has received encouraging feedback from the FDA on its planned Phase 2 HER2 breast cancer clinical trial, paving the way for its Investigational New Drug application submission later this year.
Ada Torres
Ada Torres
10 July 2025
Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.
Ada Torres
Ada Torres
9 July 2025
Resonance Health is expanding its clinical trial operations with a third TrialsWest site in Mandurah, WA, set to open in August 2025, enhancing participant recruitment and supporting ongoing pharmaceutical trials.
Ada Torres
Ada Torres
8 July 2025